CClinicalTrials.gg
SuspendedNCT04435639Updated Oct 26, 2024

Using an Adjustable Compression Garment for Secondary Upper Limb Lymphoedema

An interventional study of Manual lymph drainage. and Coban compression bandage.. in Lymphedema of Upper Arm, sponsored by Institute of Technology, Sligo. Suspended at 1 site in Ireland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-26.

Sponsored by Institute of Technology, Sligo · Not applicable, Interventional, and Treatment

Why this study was suspended
Researcher unable to continue.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This is a pilot randomised controlled trial investigating the use of an adjustable compression garment in the treatment of patients with Breast Cancer related upper limb Lymphoedema. This study will be conducted as part of a MSc qualification at the Institute of Technology Sligo in Ireland with all therapy sessions taking place in the Physiotherapy Department of Sligo University Hospital (formerly Sligo General Hospital). The study will be conducted in conjunction with Sligo University Hospital and it has attained ethical approval through the relevant University Hospital Ethics Committee.

Read the detailed description

The experimental group will receive 5 treatments followed by a final assessment on the 6th visit over a 3 week period: participants will receive manual lymphatic drainage for 40 minutes. They will then put on an Adjustable Compression sleeve (Juzo varocare adjustable compression system). Patients will be re-measured before the fourth treatment and again on session 6. At this point patients will receive a standard arm compression sleeve. This will be worn in alternation with their adjustable compression sleeve over the following 6 months. Patient will have their limb volume re-measured at the 6 month review.

The control group will receive 5 treatments followed by a final assessment on the 6th visit over a 3 week period: participants will receive manual lymphatic drainage for 40 minutes. They will then have their arm wrapped in Coban compression bandaging which will stay on until their next treatment. This will occur twice weekly for a period of 3 weeks. Patients will be Re-measured before the fourth treatment and again on session 6. At this point they will attend occupational therapy where they will receive 2 standard arm compression sleeves. The patient wears 1 sleeve every day over the following 6 months. Patient will have their limb volume re-measured at the 6 month review.

02

Conditions studied

  • Lymphedema of Upper Arm

Browse trials for

Keywords

  • Breast cancer related lymphoedema.
  • Compression bandaging.
03

In context

Lymphedema

560 studies on the registry are indexed under Lymphedema; 135 are open to participants now.

This study's planned enrollment of 30 is below the median of 50 across 403 interventional studies indexed under Lymphedema.

Browse Lymphedema studies →

Lead sponsor

Institute of Technology, Sligo is the lead sponsor of 8 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Upper limb lymphoedema (secondary to breast cancer) diagnosed by a consultant
  • Aged > 18 years.
  • Males and females.
  • Stage 2 Lymphoedema.
  • >10% volume difference between upper limbs.
  • Cognitive ability to understand the programme.

Exclusion criteria

Exclusion Criteria:

  • Involvement in other studies or rehabilitation programmes.
  • Active infection disease progression.
  • Congestive Cardiac Failure.
  • Non-English speakers.
  • Under 18's.
  • Poor cognition for treatment compliance or consent.
  • Pregnant, or currently breast feeding.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    MLD + Adjustable Compression Sleeve.

    Manual lymph drainage + Adjustable Compression Sleeve.

    Other: Manual lymph drainage. · Device: Adjustable Compression Sleeve

  • Active comparator
    MLD + Coban Compression Bandage.

    Manual lymphatic drainage + Coban compression bandaging.

    Other: Manual lymph drainage. · Procedure: Coban compression bandage..

Interventions

  • OtherManual lymph drainage.

    Manual Lymphatic drainage: Patients will receive manual lymphatic drainage by massage for 40 minutes for 5 treatments over a 15 day period.

  • ProcedureCoban compression bandage..

    Coban compression bandaging: Patients will be wrapped in Coban compression bandaging which stays on until the next treatment. Patients will wear standard compression sleeves during the six month maintenance phase.

  • DeviceAdjustable Compression Sleeve

    Patients wear an adjustable compression sleeve (Juzo varocare adjustable compression system) between treatments. They will be shown how to put it on and how to tighten the sleeve when needed. Patients will also wear the adjustable compression sleeve in alternation with a standard compression sleeve over a six month maintenance phase.

06

What researchers measure

Primary outcomes

  1. Limb Volume - Circumferential Measurements.

    Limb Volume- circumferential measurements taken at 4cm intervals from the wrist up to the axilla. The circumferences were then entered into a spreadsheet and a truncated cone formula applied with each segment volume calculated: Vs = h(Ct x Ct + Ct x Cb x Cb) 12 π where (Vs) was volume of a segment, (h) was the distance between two points of measurement, (Ct) represented the circumference at the top measurements of the segment, (Cb) represented the circumference at the base of the segment, π = Pi. Once each segment is calculated, the sum of all segments of the arm are computed into a volume estimate. This method was found to be valid (criterion validity)in several studies when compared to the gold standard of water displacement with intra-class correlation coefficient (ICC) of \>0.95. The higher the score the more lymphoedema present.

    Time frame: Over a 6 month period. (10 min testing time)

  2. Short Form 36 (SF-36): Quality of Life questionnaire.

    SF-36 is a set of generic, coherent, and easily administered quality-of-life measures. These measures rely upon patient self-reporting for routine monitoring and assessment of care outcomes in adult patients.It is scored 0-100 with a lower score indicating more disability.

    Time frame: Over a 6 month period. (10 min testing time)

07

Study locations

1 site
  • Atlantic Technological University
    Sligo, Ireland
08

References and documents

Study documents

  • Study protocol · Mar 26, 2020
  • Statistical analysis plan · Mar 26, 2020
  • Informed consent form · Oct 23, 2019

Documents are hosted by the registry — open the source record to download them.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04435639
Lead sponsor
Institute of Technology, Sligo
Collaborators
Sligo General Hospital
Responsible party
Sponsor
First posted
Jun 17, 2020
Start date
Oct 30, 2025 (estimated)
Primary completion
Apr 30, 2026 (estimated)
Completion
Jan 31, 2027 (estimated)
Last update
Oct 26, 2024

Study contacts

Shane Gallagher, MSc
principal investigator · Study Principal Investigator

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is suspended, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion